Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05408117 · ClinicalTrials.gov registry record · NA

Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color

A NA study of Scar, sponsored by Melissa Pugliano-Mauro.

Recruiting
Registry status
NA
Development phase
34
Enrollment target
3
Study locations

NCT05408117 is a NA study of Scar that is actively recruiting participants, run by Melissa Pugliano-Mauro. The registered enrollment target is 34 participants, below the 47-participant average among 15 other Scar trials with a reported enrollment target (28% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05408117, a NA study of Scar, is actively recruiting participants, sponsored by Melissa Pugliano-Mauro.

RECRUITING
Registry status
NA
Development phase
34 participants
Enrollment target
3
Study locations

Study Summary

The present study assesses if dissolvable (fast gut) or non-dissolvable (polypropylene) epidermal sutures produce better cosmetic results in terms of dyspigmentation and scarring in patients of skin of color. Through a split-wound study design, patients undergoing standard elliptical excisions at least 3 cm in length will receive each suture type. Measurements of dyspigmentation and scarring will be made at 7 days (for the head and neck), 10 days (for the trunk and extremities), and 3 months for all locations.

Conditions Studied

Interventions

  • DEVICE 5-0 Polypropylene epidermal suture
  • DEVICE 5-0 Fast gut epidermal suture

Study Locations (3)

Pennsylvania

  • UPMC Presbyterian - Pittsburgh
  • UPMC St. Margaret - Pittsburgh
  • UPMC Shadyside Place - Pittsburgh

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2022-10-01
Est. Completion 2026-10-01
Phase NA

Sponsor

Melissa Pugliano-Mauro

3 total trials

What the Registry Record Tells You About NCT05408117

The ClinicalTrials.gov registry entry for NCT05408117 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47-participant average among 15 other Scar trials with a reported enrollment target (28% lower). The listed sponsor is Melissa Pugliano-Mauro, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Scar appearing as the primary indexed condition, and to 2 interventions - of which 5-0 Polypropylene epidermal suture is the first listed.

NCT05408117 reports 3 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05408117 about?

NCT05408117 is a clinical study titled "Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color". The present study assesses if dissolvable (fast gut) or non-dissolvable (polypropylene) epidermal sutures produce better cosmetic results in terms of dyspigmentation and scarring in patients of skin of color. Through a split-wound study design, patients undergoing standard elliptical excisions at le...

What is the current status of trial NCT05408117?

This trial is currently recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2022-10-01. Estimated completion is 2026-10-01.

What conditions does trial NCT05408117 study?

This clinical trial studies the following conditions: Scar.

What interventions are being tested in trial NCT05408117?

The interventions under investigation include: 5-0 Polypropylene epidermal suture (DEVICE), 5-0 Fast gut epidermal suture (DEVICE).

Who is sponsoring clinical trial NCT05408117?

This trial is sponsored by Melissa Pugliano-Mauro, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05408117 being conducted?

This trial has 3 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Scar

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.